Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HIV drug resistance and viral fitness.
Clavel F, Race E, Mammano F. Clavel F, et al. Adv Pharmacol. 2000;49:41-66. doi: 10.1016/s1054-3589(00)49023-x. Adv Pharmacol. 2000. PMID: 11013760 Review. No abstract available.
Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease inhibitors predicts outcome of therapy.
Piketty C, Race E, Castiel P, Belec L, Peytavin G, Si-Mohamed A, Gonzalez-Canali G, Weiss L, Clavel F, Kazatchkine MD. Piketty C, et al. Among authors: clavel f. AIDS. 1999 Jul 30;13(11):F71-7. doi: 10.1097/00002030-199907300-00001. AIDS. 1999. PMID: 10449277 Clinical Trial.
Discordant increases in CD4+ T cells in human immunodeficiency virus-infected patients experiencing virologic treatment failure: role of changes in thymic output and T cell death.
Lecossier D, Bouchonnet F, Schneider P, Clavel F, Hance AJ; Centre de Recherche Integré sur le VIH Bichat-Claude Bernard. Lecossier D, et al. Among authors: clavel f. J Infect Dis. 2001 Apr 1;183(7):1009-16. doi: 10.1086/319285. Epub 2001 Mar 8. J Infect Dis. 2001. PMID: 11237824
Phenotypic resistance to protease inhibitors in patients who fail on highly active antiretroviral therapy predicts the outcome at 48 weeks of a five-drug combination including ritonavir, saquinavir and efavirenz.
Piketty C, Race E, Castiel P, Belec L, Peytavin G, Si-Mohamed A, Gonzalez-Canali G, Weiss L, Clavel F, Kazatchkine MD. Piketty C, et al. Among authors: clavel f. AIDS. 2000 Mar 31;14(5):626-8. doi: 10.1097/00002030-200003310-00025. AIDS. 2000. PMID: 10780732 No abstract available.
178 results